fracture risk reduction Recently Published Documents

Meta-analysis of clinical fracture risk reduction of anti-osteoporosis drugs: direct and indirect comparisons and meta-regressions

Endocrine Practice ◽

10.1016/j.eprac.2021.06.015 ◽

2021 ◽

Author(s):

Stewart G. Albert ◽

Emily Wood

Keyword(s):

Fracture Risk ◽

Risk Reduction ◽

Meta Analysis ◽

Clinical Fracture ◽

Fracture Risk Reduction ◽

Indirect Comparisons

Bone mineral density as a surrogate biomarker for fracture risk reduction

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(20)30338-7 ◽

2020 ◽

Vol 8 (11) ◽

pp. 875

Author(s):

Viral N Shah

Keyword(s):

Bone Mineral Density ◽

Fracture Risk ◽

Risk Reduction ◽

Bone Mineral ◽

Mineral Density ◽

Bone mineral density as a surrogate biomarker for fracture risk reduction – Authors' reply

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(20)30340-5 ◽

2020 ◽

Vol 8 (11) ◽

pp. 876

Author(s):

Dennis M Black ◽

Mary L Bouxsein ◽

Douglas C Bauer ◽

Richard Eastell

Keyword(s):

Bone Mineral Density ◽

Fracture Risk ◽

Risk Reduction ◽

Bone Mineral ◽

Mineral Density ◽

Fracture Risk Reduction by Bisphosphonates in Mastocytosis?

The Journal of Allergy and Clinical Immunology In Practice ◽

10.1016/j.jaip.2020.06.054 ◽

2020 ◽

Vol 8 (10) ◽

pp. 3557-3564

Author(s):

Merel C. Onnes ◽

Jasper J. van Doormaal ◽

Eveline van der Veer ◽

Joris B. Versluijs ◽

Suzanne Arends ◽

...

Keyword(s):

Fracture Risk ◽

Risk Reduction ◽

Bone mineral density as a surrogate biomarker for fracture risk reduction

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(20)30339-9 ◽

2020 ◽

Vol 8 (11) ◽

pp. 875-876

Author(s):

Josivan G Lima ◽

Lucia H C Nóbrega ◽

Marcel C F Santos ◽

Breno C C Simas

Keyword(s):

Bone Mineral Density ◽

Fracture Risk ◽

Risk Reduction ◽

Bone Mineral ◽

Mineral Density ◽

Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained

Journal of Bone and Mineral Research ◽

10.1002/jbmr.4178 ◽

2020 ◽

Author(s):

Richard Eastell ◽

Dennis M Black ◽

Li‐Yung Lui ◽

Arkadi Chines ◽

Fernando Marin ◽

...

Keyword(s):

Clinical Trials ◽

Bone Turnover ◽

Fracture Risk ◽

Risk Reduction ◽

Treatment Effect ◽

Fracture Risk Reduction ◽

Decision letter for "Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained"

10.1002/jbmr.4178/v3/decision1 ◽

2020 ◽

Keyword(s):

Clinical Trials ◽

Bone Turnover ◽

Fracture Risk ◽

Risk Reduction ◽

Treatment Effect ◽

Fracture Risk Reduction ◽

Review for "Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained"

10.1002/jbmr.4178/v3/review1 ◽

2020 ◽

Keyword(s):

Clinical Trials ◽

Bone Turnover ◽

Fracture Risk ◽

Risk Reduction ◽

Treatment Effect ◽

Fracture Risk Reduction ◽

Author response for "Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained"

10.1002/jbmr.4178/v3/response1 ◽

2020 ◽

Author(s):

Richard Eastell ◽

Dennis M. Black ◽

Li‐Yung Lui ◽

Arkadi Chines ◽

Fernando Marin ◽

...

Keyword(s):

Clinical Trials ◽

Bone Turnover ◽

Fracture Risk ◽

Risk Reduction ◽

Treatment Effect ◽

Author Response ◽

Fracture Risk Reduction ◽